Nature Reviews Cancer 17, 254–268 (2017)
In the online html version of this article, Joan Seoane's affiliations were not correct. He is also a member of the EurOPDX Consortium and is at the Vall d'Hebron Institute of Oncology, 08035 Barcelona, the Universitat Autònoma de Barcelona, 08193 Bellaterra, and the Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. This is correct in the print and PDF versions of the article.
Change history
31 October 2017
When the October issue was published online, this article was initially missed out. It has now been moved into the issue. The article was correctly included in the print edition.
Additional information
The online version of the original article can be found at 10.1038/nrc.2016.140
Rights and permissions
About this article
Cite this article
Byrne, A., Alférez, D., Amant, F. et al. Erratum: Interrogating open issues in cancer medicine with patient-derived xenografts. Nat Rev Cancer 17, 632 (2017). https://doi.org/10.1038/nrc.2017.85
Published:
Issue Date:
Further reading
-
Progress in the application of organoids to breast cancer research
Journal of Cellular and Molecular Medicine (2020)
-
Patient-derived xenografts (PDXs) as model systems for human cancer
Current Opinion in Biotechnology (2020)
-
The ongoing trends of patient‐derived xenograft models in oncology
Cancer Communications (2020)
-
Implementation of the Chick Chorioallantoic Membrane (CAM) Model in Radiation Biology and Experimental Radiation Oncology Research
Cancers (2019)
-
Modelling CAR-T therapy in humanized mice
EBioMedicine (2019)